Prognostic factors of advanced Hodgkin’s lymphoma: multivariate analysis of 199 Chinese patients with long-term follow-up.
Lists
Only you see this
Abstract
e19021 Background: About 30% of advanced HL patients will suffer relapse and some may be overtreated. More accurate methods are needed to identify patients with different prognosis. The current International Prognostic Score (IPS) is imperfect and there is almost no data about prognostic factors of advanced HL in the Chinese population until now. Methods: We conducted a retrospective study involving 199 Chinese advanced HL patients admitted to Cancer Hospital Chinese Academy of Medical Sciences (CHCAMS) from 1999.1 to 2015.1. All patients received standard first-line therapy. Survival outcome and 18 parameters at diagnosis of the 199 patients were collected and analyzed to identify independent prognostic factors. Treatment regimen of cases with progressed or recurrent disease were not uniform, and some patients died of toxicity or other diseases, so we analyzed factors affecting progression-free survival (PFS), but not overal survival (OS). Results: The median follow-up time was 66.4 months (range 9.4-200.5 months).Three factors showed significant independent prognostic value for PFS in the multivariate analysis: lymphocyte/monocyte ratio (LMR) < 2.67 (HR = 1.976, 95%CI, 1.193-3.272, P = 0.008), serum albumin < 4g/dL (HR = 1.703, 95%CI, 1.034-2.805, P = 0.037), serum beta-2 macroglobulin (B2MG) ≥ normal (HR = 1.836,95%CI, 1.114-3.026,P = 0.017). Prognostic score was calculated by adding 1 point each for any of the independent prognostic factors. According to the prognostic scores, patients could be divided into low (0 points), intermediate (1-2 points) and high (3 points) risk groups with 5-year PFS rate of 88.4%, 62.8% , 27.5% (0 vs.1-2, P = 0.001; 1-2 vs.3, P = 0.019; 0 vs.3,P = 0.000) and 5-year OS of 95.4%, 79.8%, 43.9% ( 0 vs.1-2, P = 0.009; 1-2 vs.3, P = 0.001; 0 vs.3, P = 0.000) respectively. Conclusions: Three factors were recognized as independent prognostic factors for Chinese advanced HL patients and a prognostic scoring system was established, according to which patients with different prognosis will be identified and more appropriate therapies could be made to increase the cure rate of patients with high risk for replase and avoid overtreatment in patients with lower risk.
BibTeX
@article{wang2016prognostic,
author = {Qin Wang and Yan Qin and Suyi Kang and Xiaohui He and Peng Liu and Sheng Yang and Shengyu Zhou and Changgong Zhang and Lin Gui and Jianliang Yang and Yan Sun and Yuankai Shi},
title = {{Prognostic factors of advanced Hodgkin’s lymphoma: multivariate analysis of 199 Chinese patients with long-term follow-up.}},
journal = {Journal of Clinical Oncology},
year = {2016},
doi = {10.1200/jco.2016.34.15\_suppl.e19021},
}Loading related content...